Q1 Earnings Estimate for Ayr Wellness Issued By Roth Capital

Ayr Wellness Inc. (OTCMKTS:AYRWFFree Report) – Equities researchers at Roth Capital dropped their Q1 2025 earnings per share (EPS) estimates for Ayr Wellness in a research report issued on Monday, March 10th. Roth Capital analyst W. Kirk now expects that the company will post earnings of ($0.34) per share for the quarter, down from their previous forecast of ($0.32). The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.31) per share. Roth Capital also issued estimates for Ayr Wellness’ Q2 2025 earnings at ($0.32) EPS, FY2025 earnings at ($1.26) EPS and FY2026 earnings at ($1.14) EPS.

Ayr Wellness (OTCMKTS:AYRWFGet Free Report) last released its earnings results on Thursday, March 6th. The company reported ($0.41) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.12). The company had revenue of $113.96 million during the quarter, compared to the consensus estimate of $114.10 million. Ayr Wellness had a negative net margin of 48.17% and a negative return on equity of 25.30%.

Other analysts also recently issued reports about the company. Atb Cap Markets downgraded Ayr Wellness from a “hold” rating to a “strong sell” rating in a research note on Wednesday, November 13th. Roth Mkm cut their target price on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating on the stock in a research note on Thursday, November 14th. Finally, Ventum Cap Mkts cut Ayr Wellness from a “strong-buy” rating to a “hold” rating in a report on Friday, March 7th.

View Our Latest Analysis on Ayr Wellness

Ayr Wellness Stock Up 6.9 %

AYRWF stock opened at $0.17 on Thursday. Ayr Wellness has a fifty-two week low of $0.16 and a fifty-two week high of $3.46. The business’s 50 day moving average price is $0.41 and its two-hundred day moving average price is $1.02. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.58 and a current ratio of 1.59. The company has a market capitalization of $19.75 million, a price-to-earnings ratio of -0.08 and a beta of 1.70.

Ayr Wellness Company Profile

(Get Free Report)

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.

Read More

Earnings History and Estimates for Ayr Wellness (OTCMKTS:AYRWF)

Receive News & Ratings for Ayr Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayr Wellness and related companies with MarketBeat.com's FREE daily email newsletter.